世界の緩和ケア市場は、予測期間中に8.69％のCAGRで大きく拡大し、2027年末までに2,823億710万ドルを超えると予想されます。緩和ケアは、悪性腫瘍などの本物のまたは危険な疾患がある患者個人の満足度を高めるために行われ、患者は治療により安心感が持てるようになります。緩和ケアは、診療所、長期療養型施設、短期センター、または臨床医の管理下にある在宅医療で患者に提供されます。悪性腫瘍や心血管疾患などの危険な感染症の増加が、世界の緩和ケア市場を牽引しています。
外傷や交通事故の増加によって修復管理を必要とする患者が増えているため、緩和ケア管理への関心が高まっています。一方で、一部には緩和ケアサービスが利用できない国もあり、市場の成長を妨げる可能性があります。
目次
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING INSTANCES OF LIFE-THREATENING DISEASES
4.2.2 GROWING NUMBER OF PALLIATIVE CARE CENTERS WORLDWIDE
4.3 RESTRAINT
4.3.1 LACK OF ACCESS TO PALLIATIVE CARE SERVICES IN DEVELOPING AND UNDERDEVELOPED COUNTRIES
4.4 OPPORTUNITY
4.4.1 GROWING GERIATRIC POPULATION
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY)
5.1.2 SERVICE CUSTOMIZATION
5.1.3 CUSTOMER PURCHASE SUPPORT
5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON PALLIATIVE CARE MARKET
5.3.1 OVERVIEW
5.3.2 IMPACT ON DEMAND FOR PALLIATIVE CARE
6 GLOBAL PALLIATIVE CARE MARKET, BY TYPES
6.1 INTRODUCTION
6.2 HOSPITAL INPATIENT CARE
6.3 HOSPICE INPATIENT CARE
6.4 NURSING HOMES
6.5 RESIDENTIAL FACILITY CARE
6.6 HOMECARE
6.7 PRIVATE RESIDENCE CARE
7 GLOBAL PALLIATIVE CARE MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CARDIAC DISEASE
7.3 CONGESTIVE HEART FAILURE (CHF)
7.4 CANCER
7.5 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
7.6 KIDNEY FAILURE
7.7 ALZHEIMER’S DISEASE
7.8 PARKINSON’S DISEASE
7.9 AMYOTROPHIC LATERAL SCLEROSIS (ALS)
7.10 OTHERS
8 GLOBAL PALLIATIVE CARE MARKET, BY END USER
8.1 INTRODUCTION
8.2 LONG TERM CARE CENTERS & REHABILITATION CENTERS
8.3 HOSPITALS & CLINICS
8.4 PALLIATIVE CARE CENTERS
8.5 HOME CARE SETTINGS
9 GLOBAL PALLIATIVE CARE MARKET, BY REGION
9.1 INTRODUCTION
9.2 AMERICAS
9.2.1 NORTH AMERICA
9.2.1.1 US
9.2.1.2 CANADA
9.2.2 SOUTH AMERICA
9.3 EUROPE
9.3.1 WESTERN EUROPE
9.3.1.1 GERMANY
9.3.1.2 UK
9.3.1.3 FRANCE
9.3.1.4 ITALY
9.3.1.5 SPAIN
9.3.1.6 REST OF WESTERN EUROPE
9.3.2 EASTERN EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 REST OF ASIA PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST
9.5.2 AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL PALLIATIVE CARE MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PALLIATIVE CARE MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 MERGER/ACQUISITION
10.6.2 COLLABORATION/ AGREEMENT
10.6.3 EXPANSION/INVESTMENT
10.7 FINANCIAL MATRIX
10.7.1 SALES (USD MILLION), 2020
11 COMPANY PROFILES
11.1 VITAS HEALTHCARE CORPORATION
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS/SERVICES OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 SUNRISE SENIOR LIVING, LLC
11.2.1 COMPANY OVERVIEWS
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS/SERVICES OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 KEY STRATEGIES
11.3 HOME INSTEAD, INC.
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS/SERVICES OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIES
11.4 AMEDISYS, INC.
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 GENESIS HEALTHCARE, INC.
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 WOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 LHC GROUP, INC.
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 REVERA INC.
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIES
11.8 FC COMPASSUS LLC.
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS/SERVICES OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGIES
11.9 KINDRED HEALTHCARE INCORPORATED
11.9.1 COMPANY OVERVIEWS
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS/SERVICES OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGIES
11.10 SEYMOUR HEALTH
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS/SERVICES OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS
